Differential sensitivities of MRP1-overexpressing lung tumor cells to cytotoxic metals

Toxicology

Volumn 142, Issue 2, 1999, Pages 127-134

  Vernhet, Laurent ^a   Allain, Nathalie ^a   Bardiau, Caroline ^a   Anger, Jean Pierre ^a   Fardel, Olivier ^a  

^a INSERM   (France)

Author keywords

Antimony; Arsenic; ATP binding cassette transporters; Human tumor cells; Inorganic mercury; Metal resistance; Metal transport; Metals; Multidrug resistance associated protein 1

Indexed keywords

ANTIMONY; ANTINEOPLASTIC AGENT; ARSENIC; HEAVY METAL; MERCURY; MULTIDRUG RESISTANCE PROTEIN; VERLUKAST; VINCRISTINE;

ARTICLE; CONTROLLED STUDY; DRUG RESISTANCE; HUMAN; HUMAN CELL; LUNG TUMOR; PRIORITY JOURNAL; TOXICITY TESTING; XENOBIOTIC METABOLISM;

EID: 0344822637     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(99)00148-1     Document Type: Article

References (29)

1. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
2. Carmichael J., DeGraff W.G., Gazdar A.F., Minna J.D., Mitchell J.B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res. 47:1987;936-942.
3. Chen Z.-S., Mutoh M., Sumizawa T., Furukawa T., Haraguchi M., Tani A., Akiyama S. Reversal of heavy metal resistance in multidrug-resistant human KB carcinoma cells. Biochem. Biophys. Res. Commun. 236:1997;586-590.
4. Cherian, M.G., 1995. Metallothionein and its interaction with metals. In: Goyer, R.A., Cherian, G. (Eds.), Toxicology of Metals, Biochemical Aspects. Springer-Verlag, Berlin, Heidelberg, pp. 121-137.
5. Cole S.P.C., Bhardwaj G., Gerlach J.H., Mackie J.E., Grant C.E., Almquist K.C., Stewart A.J., Kurz E.U., Duncan A.M., Deeley R.G. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science. 258:1992;1650-1654.
6. Cole S.P.C., Sparks K.E., Fraser K., Loe D.W., Grant C.E., Wilson G.M., Deeley R.G. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res. 54:1994;5902-5910.
7. Feller N., Broxterman H.J., Währer D.C., Pinedo H.M. ATP-dependent efflux of calcein by the multidrug resistance-associated protein (MRP): no inhibition by intracellular glutathione depletion. FEBS Lett. 368:1995;385-388.
8. Flens M.J., Zaman G.J., van der Valk P., Izquierdo M.A., Schroeijers A.B., Scheffer G.L., van den Groep P., de Haas M., Meijer C.J., Scheper R.J. Tissue distribution of the multidrug resistance protein. Am. J. Pathol. 148:1996;1237-1247.
9. Gekeler V., Ise W., Sanders K.H., Ulrich W.R., Beck J. The leukotriene LTD4 receptor antagonist MK571 specificially modulates MRP associated multidrug resistance. Biochem. Biophys. Res. Commun. 208:1995;345-352.
10. Huang R.-N., Lee T.-C. Arsenite efflux is inhibited by verapamil, cyclosporin A, and GSH-depleting agents in arsenite-resistant chinese hamster ovary cells. Toxicol. Appl. Pharmacol. 141:1996;17-22.
11. Jones T.R., Zamboni R., Belley M. et al. Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist. Can. J. Physiol. Pharmacol. 67:1989;17-28.
12. Kaur P., Rosen B.P. Plasmid-encoded resistance to arsenic and antimony. Plasmid. 27:1992;29-40.
13. Keppler D., König J. Expression and localization of the conjugate export pump encoded by the MRP2 (cMRP/cMOAT) gene in liver. FASEB J. 11:1997;509-516.
14. Kurdi-Haidar B., Heath S.A., Enns R.E., Naredi P., Hom D.K., Howell S.B. Isolation of the ATP-binding human homolog of the arsA component of the bacterial arsenite transporter. Genomics. 36:1996;486-491.
15. Loe D.W., Deeley R.G., Cole S.P.C. Biology of the multidrug resistance-associated protein, MRP. Eur. J. Cancer. 32A:1996;945-957.
16. Loe D.W., Almquist K.C., Deeley R.G., Cole S.P.C. Multidrug resistance protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles. J. Biol. Chem. 271:1996;9675-9682.
17. Loe D.W., Deeley R.G., Cole S.P.C. Characterization of vincristine transport by the Mr 190 000 multidrug resistance protein (MRP): evidence for co-transport with reduced glutathione. Cancer Res. 58:1998;5130-5136.
18. Naredi P., Heath D.D., Enns R.E., Howell S.B. Cross-resistance between cisplatin, antimony potassium tartrate and arsenite in human tumor cells. J. Clin. Invest. 95:1995;1193-1198.
19. Priebe W., Krawczyk M., Kuo M.T., Yamane Y., Savaraj N., Ishikawa T. Doxorubicin- and daunorubicin-glutathione conjugates, but not unconjugated drugs, competitively inhibit leukotriene C4 transport mediated by MRP/GS-X pump. Biochem. Biophys. Res. Commun. 247:1998;859-863.
20. Rappa G., Lorico A., Flavell A., Sartorelli A. Evidence that the multidrug resistance protein (MRP) functions as a co-transporter of glutathione and natural toxins. Cancer Res. 57:1997;5232-5237.
21. Scott N., Hatledid K.M., MacKenzie N.E., Carter D.E. Reaction of arsenic(III) and arsenic(V) species with glutathione. Chem. Res. Toxicol. 6:1993;102-106.
22. Shen D., Pastan I., Gottesman M. Cross-resistance to methotrexate and metals in human cisplatin-resistant cell lines results from a plieotropic defect in accumulation of these compounds associated with reduced plasma membrane binding proteins. Cancer Res. 58:1998;268-275.
23. Soignet S.L., Maslak P., Wang Z.-G., Jhanwar S., Calleja E., Dardashti L.J., Corso D., DeBlasio A., Gabrilove J., Scheinberg D.A., Pandolfi P.P., Warrell R.P. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxyde. New Engl. J. Med. 339:1998;1341-1348.
24. Stride B.D., Grant C.E., Loe D.W., Hipfner D.R., Cole S.P.C., Deeley R.G. Pharmacological characterization of the murine and human orthologs of multidrug-resistance protein in transfected human embryonic kidney cells. Mol. Pharmacol. 52:1997;344-353.
25. Sugawara N., Lai Y.-R., Sugaware C., Arizono K. Decreased hepatobiliary secretion of inorganic mercury, its deposition and toxicity in the Eisai hyperbilirubinemic rat with no hepatic canalicular organic anion transporter. Toxicology. 126:1998;23-31.
26. Vernhet L., Courtois A., Payen L., Allain N., Anger J.-P., Guillouzo A., Fardel O. Overexpression of the multidrug resistance-associated protein (MRP1) in human heavy metal-selected tumor cells. FEBS Lett. 443:1999;321-325.
27. Wang H.F., Lee T.C. Glutathione S-transferase pi facilitates the excretion of arsenic from arsenic-resistant Chinese hamster ovary cells. Biochem. Biophys. Res. Commun. 192:1993;1093-1099.
28. Zaman G.J.R., Lankelma J., van Tellingen O., Beijnen J., Dekker H., Paulusma C., Oude-Elferink R.P., Baas F., Borst P. Role of glutathione in export of compounds from cells by the multidrug resistance-associated protein. Proc. Natl. Acad. Sci. 92:1995;7690-7694.
29. Ziljstra J.G., de Vries E.G., Mudler N.H. Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line. Cancer Res. 47:1987;1780-1784.